The lab intends to contribute to the development of new therapies for chronic inflammation, e. in chronic kidney disease and autoimmunity. Our research interests touch the fields of nephrology, immunology, and rheumatology. The lab is part of the. Embedded in the academic environment of the. And international networks we focus on the identification and validation of new targets in experimental disease models.

National University of Ireland, Galway. The Belfast Health and Social Care Trust. Istituto di Ricerche Farmacologiche Mario Negri. University Hospital Birmingham NHS Foundation Trust. Azienda Ospedaliera Papa Giovanni XXIII Bergamo. This trial will evaluate the clinical safety and efficac.

Improving the Success Rate of Corneal Transplants. Corneal disease is a leading cause of blindness worldwide and affects individuals of both genders and of all age groups. THERE ARE OVER 100,000. VISICORT WILL PROFILE DATA FROM 700 CORNEAL TRANSPLANT RECIPIENTS. TO ULTIMATELY IMPROVE CORNEAL TRANSPLANT SUCCESS. VISICORT partners involved in exciting new stem cell project.

Project Materials, Photos, Videos and Presentations. 29 million people in the EU suffer from liver disease. Liver disease includes a range of diseases and symptoms, most of which have a significant inflammatory. Learn More About the Project.